Drug Development

4 articles

Pharmaceutical scientist analyzing molecular data, representing the complex balance between drug efficacy and patient tolerability in obesity treatment.

Boehringer's obesity drug shows efficacy, faces tolerability challenge

In a pivotal Phase 3 obesity trial, 19% of patients on Boehringer Ingelheim and Zealand Pharma's experimental drug survodutide discontinued treatment due to severe gastrointestinal side effects, a rat

Yasmin Haddad·June 8, 2026

A scientist in a futuristic lab examining a holographic display of a triple hormone receptor drug, representing Pfizer's new obesity treatment.

Cosmos & Physics

Pfizer advances monthly obesity drug targeting triple hormone receptors

Pfizer is advancing a monthly weight-loss injection, danuglipron, having announced positive early-stage data.

Dr. Evelyn Reed·June 7, 2026

Microscopic view of cancer cells being targeted by a futuristic drug, symbolizing hope and the fight against pancreatic cancer.

Cosmos & Physics

Revolution Medicines Reports Promising Pancreatic Cancer Drug Results

Patients with previously treated metastatic pancreatic cancer lived an average of 13 additional months with Revolution Medicines' new drug, daraxonrasib, more than double the survival rate of standard

Dr. Evelyn Reed·May 31, 2026

Microscopic view of Hepatitis B virus particles being neutralized by an experimental drug, symbolizing a functional cure.

Cosmos & Physics

GSK's New Drug Functionally Cures Hepatitis B in Nearly 20% of Patients

In late-stage trials, GSK's experimental drug bepirovirsen achieved a functional cure for nearly one in five chronic hepatitis B patients, a first for the disease, according to Reuters .

Dr. Evelyn Reed·May 28, 2026